Dianthus Therapeutics DNTH
NASDAQ DNTH
$89.30 +0.49 (+0.55%)
At close: Nov 11, 2026 · 4:00 PM EST

Dianthus Therapeutics (DNTH) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Dianthus Therapeutics (DNTH) posted Return on Capital Employed [ROCE] of -32.79% for Q3 2025, down 8.82 percentage points from -23.97% a year earlier but up 8.16 percentage points from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2024, Dianthus Therapeutics' Return on Capital Employed [ROCE] came in at -39.44%, up 0.16 percentage points from FY2023.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +17.66 percentage points (FY2019 to FY2024).
  • In prior years, Dianthus Therapeutics' Return on Capital Employed [ROCE] was -39.61% in FY2023 (-16.45 pp), -23.15% in FY2022 (+22.14 pp), -45.29% in FY2021 (+7.13 pp) and -52.42% in FY2020 (+4.68 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -57.85% in Q1 2023 to a high of -18.80% in Q2 2024 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last four quarters, with an average year-over-year change of +7.59 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 36.40 percentage points; the weakest was Q2 2025, with a drop of 22.15 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -40.95% (Q2 2025), -34.04% (Q1 2025) and -29.47% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Dianthus Therapeutics 5.00 Bn 4.95 Bn - -19.41%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -19.41%
Jun 30, 2026 -18.22%
Mar 31, 2026 -22.49%
Dec 31, 2025 -33.99%
Sep 30, 2025 -32.79%
Jun 30, 2025 -40.95%
Mar 31, 2025 -34.04%
Dec 31, 2024 -29.47%
Sep 30, 2024 -23.97%
Jun 30, 2024 -18.80%
Mar 31, 2024 -21.45%
Dec 31, 2023 -27.32%
Sep 30, 2023 -37.49%
Jun 30, 2023 -49.87%
Mar 31, 2023 -57.85%
Dec 31, 2022 -52.75%
Sep 30, 2022 -44.87%
Jun 30, 2022 -46.28%
Mar 31, 2022 -44.83%
Dec 31, 2021 -39.89%
API Access

Dianthus Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DNTH&period=max&api_key=YOUR_API_KEY